Breakthrough research reveals how ETS inhibitors YK-4-279 and TK-216 combine with lenalidomide to target resistant ABC DLBCL lymphoma.
Exploring Robert Sparrow's Benefit Argument and its profound implications for technology, bioethics, and our understanding of progress.
Exploring the ethical and scientific imperative to continue responsible gene editing research on human embryos to prevent genetic diseases.
Exploring how glioblastoma organoids (GBOs) are revolutionizing personalized brain cancer therapy through 3D tissue models that mimic patient tumors.
Explore how CRISPR-Cas9 is transforming hematology, from curing sickle cell disease to personalized gene therapies for rare blood disorders.
Exploring how knowledge and values influence attitudes toward gene editing technologies among farmers, scientists, policymakers, and the public.
An in-depth look at the CRISPR baby scandal, its ethical implications, and the future of human gene editing
Exploring how AI and drone technologies are reshaping human evolution and forcing us to reconsider our place in the cosmos.
Exploring the transformative potential of stem cell therapies in regenerative medicine and disease treatment.
Discover how CRISPR-edited organoids are revolutionizing cancer research by decoding mutational signatures and revealing cancer origins.